paclitaxel has been researched along with Interstitial Nephritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dong, Z; He, Z; Wang, S; Xiang, X; Xu, X; Yang, J; Yang, R; Zhang, D; Zhang, L; Zhao, Y | 1 |
| Chen, XW; Duan, W; Zhou, SF | 1 |
| Abe, K; Ishiko, O; Sumi, T; Yoshida, H | 1 |
3 other study(ies) available for paclitaxel and Interstitial Nephritis
| Article | Year |
|---|---|
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Paclitaxel; STAT3 Transcription Factor; Tubulin | 2015 |
Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Fibroblasts; Kidney; Male; Nephritis, Interstitial; Paclitaxel; STAT3 Transcription Factor | 2015 |
Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Agents; Area Under Curve; Carboplatin; Female; Humans; Middle Aged; Nephritis, Interstitial; Ovarian Neoplasms; Paclitaxel; Renal Dialysis | 2009 |